Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ronald Hunt currently holds 65,481 shares of Iterum Therapeutics plc (ITRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald Hunt has been a net buyer of ITRM stock. They have purchased $41.7M and sold $2.2M worth of shares.
Ronald Hunt's most recent insider trade was on Aug 6, 2024, when they sold 65,481 shares at $0.00 per share.
Ronald Hunt serves as Executive at Iterum Therapeutics plc (ITRM). They have executed 69 insider transactions totaling $43.9M over their tenure at the company.
Ronald Hunt holds the position of Executive at Iterum Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Ronald Hunt has shown a buying trading pattern, with $41.7M in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ronald Hunt was on Mar 23, 2023, when they purchased $10.0M worth of HARP shares. This transaction involved 10,000 shares at $1000.00 per share.
Ronald Hunt currently owns 65,481 shares of Iterum Therapeutics plc (ITRM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ronald Hunt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ronald Hunt has 69 Form 4 filings on record as an insider at Iterum Therapeutics plc.
Set alerts for Ronald Hunt and 40,000+ other insiders.